オプションチェーンは、Mapath Capitalの株式オプションの主要データを様々な行使価格と満期日で表示します。トレーダーはこの情報を使用して、潜在的な取引を分析し、Mapath Capitalの市場センチメントを評価します。.

Mapath Capital (OTC:IVFZF) 株価情報, オプションチェーン

Mapath Capital Corp is currently seeking business opportunities.

MAPATH CAPITAL CORP by MAPATH CAPITAL CORP.

Mapath Capital Corp

UBS analyst David Vogt maintains Extreme Networks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXTR#NASDAQ">EXTR</a>) with a Neutral and lowers the price target from $16.5 to $15.

News

Price Target

Analyst Ratings

EXTR

UBS Maintains Neutral on Extreme Networks, Lowers Price Target to $15

Howmet Aerospace Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HWM#NYSE">HWM</a>) stock is trading higher on Thursday after the company reported <a target="_blank" href="https://www.benzinga.com/pressreleases/25/05/b45129637/howmet-aerospace-reports-first-quarter-2025-results" rel="noreferrer noopener">first-quarter 2025 results</a>.
The company reported revenue growth of 6.5% year over year to $1.94 billion, which is in line with the consensus estimate. The increase was driven by a 9% surge in commercial aerospace sales.
Adjusted EPS stood at 86 cents (+51% YoY), beating <a target="_blank" href="https://www.benzinga.com/earnings" rel="noreferrer noopener">the consensus of 78 cents</a>.
Revenue by Segments: Engine Products $996 million (+13% YoY); Fastening Systems $412 million (+6% YoY); Engineered Structures $282 million (+8% YoY); and Forged Wheels $252 million (-13% YoY).
Also Read: <a target="_blank" href="https://www.benzinga.com/25/04/44957609/general-dynamics-delivers-strong-performance-in-q1-aerospace-segments-shows-major-profit-growth" rel="noreferrer noopener">General Dynamics Delivers Strong Performance In Q1, Aerospace Segments Shows Major Profit Growth</a>
Howmet Aerospace repurchased $125 million in stock at an average price of $124.24 per share in Q1 and $100 million in April, retiring about 1.8 million shares overall, with $1.972 billion still authorized for buybacks.
Adjusted EBITDA excluding special items was $560 million (+28.2% YoY), and the margin was 28.8%, up from 23.9% YoY. Operating income increased by 33.9% YoY to $494 million, and the margin expanded by 520 bps to 25.4%.
Operating cash flow for the quarter totaled $253 million, up from $177 million a year ago. Free cash flow remained strong at $134 million, up from $95 million a year ago. At the end of the quarter, the company&#8217;s cash balance was $536 million.
Howmet Aerospace sees continued growth in commercial aerospace, driven by rising passenger traffic, especially in Europe and Asia Pacific, despite some North American softness.
&#8220;We continue to expect healthy growth in the defense aerospace market as well as industrial and other, with demand for industrial gas turbine fueled by significant data center expansion,&#8221; commented Howmet Aerospace Executive Chairman and Chief Executive Officer John Plant.
&#8220;While the tariff situation remains fluid, we expect to pass on tariff-related costs to our customers. Taking these factors into account including the impact of tariffs, for the full year 2025 guidance, the revenue range has been widened with increases to Adjusted EBITDA, Adjusted EPS, and Free Cash Flow. The balance sheet continues to strengthen, and liquidity remains healthy.&#8221;
Q2 Outlook: Howmet Aerospace expects revenue of $1.98 billion – $2.00 billion, versus the consensus of $2.00 billion, and adjusted EPS of $0.85 – $0.87, versus the consensus of $0.81.
The company expects an Adjusted EBITDA margin of 28%—28.3%, with Adjusted EBITDA of $555 million—$565 million.
2025 Outlook updated: Howmet Aerospace now expects revenue of $7.88 billion—$8.18 billion (prior $7.93 billion—$8.13 billion) versus the consensus of $8.07 billion and adjusted EPS of $3.36-$3.44 (prior 3.13 – $3.21) versus the consensus of $3.27.
The company expects an Adjusted EBITDA margin of ~28.2% and Adjusted EBITDA of $2.225 billion—$2.275 billion in 2025.
Price Action: HWM shares are trading higher by 7.53% at $149.02 at the last check Thursday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/price-target/25/04/45017928/tariff-proof-takeoff-b-of-a-highlights-ge-aerospaces-strong-defense-against-import-c" target="_blank" rel="noreferrer noopener">Tariff-Proof Takeoff? B Of A Highlights GE Aerospace&#8217;s Strong Defense Against Import Costs</a></li>
</ul>
Photo by T. Schneider via Shutterstock

Earnings

Guidance

Movers

Howmet Aerospace Confident Of Passing Tariff Costs To Customers, Stock Takes Off

UBS analyst Chris Kuntarich maintains Etsy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ETSY#NASDAQ">ETSY</a>) with a Neutral and lowers the price target from $46 to $45.

ETSY

UBS Maintains Neutral on Etsy, Lowers Price Target to $45

Piper Sandler analyst Thomas Champion reiterates Meta Platforms (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) with a Overweight and raises the price target from $610 to $650.

Reiteration

Piper Sandler Reiterates Overweight on Meta Platforms, Raises Price Target to $650

Guggenheim analyst Debjit Chattopadhyay maintains Ionis Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IONS#NASDAQ">IONS</a>) with a Buy and lowers the price target from $65 to $64.

IONS

Guggenheim Maintains Buy on Ionis Pharmaceuticals, Lowers Price Target to $64

Apple Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) will be reporting its second-quarter earnings on Thursday. Wall Street expects $1.63 in EPS and $94.53 billion in revenues as the company reports<a href="https://www.benzinga.com/calendars/earnings?tickers=AAPL" target="_blank" rel="noreferrer noopener"> after market hours</a>.
The stock is up 25.52% over the past year, down 12.86% YTD.
Let&#8217;s look at what the charts indicate for Apple stock and how the stock currently maps against Wall Street estimates.
Read Also: <a href="https://www.benzinga.com/news/legal/25/05/45128130/google-aims-for-gemini-ai-deal-with-apple-this-year-says-sundar-pichai-amid-dojs-bid-to-curb-search-monopoly">Google Aims For Gemini AI Deal With Apple This Year, Says Sundar Pichai Amid DOJ&#8217;s Bid To Curb Search Monopoly</a>
<h2 class="wp-block-heading">Apple Stock Stuck In A Stagnant Trend Ahead Of Q2 Earnings</h2>
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0501"><img loading="lazy" decoding="async" width="627" height="489" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/01073826/Screenshot-2025-05-01-at-4.47.56-PM.png" alt="" class="wp-image-896651" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/01073826/Screenshot-2025-05-01-at-4.47.56-PM.png 627w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/01073826/Screenshot-2025-05-01-at-4.47.56-PM-300x234.png 300w" sizes="(max-width: 627px) 100vw, 627px" /></a></figure>
<a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0501">Chart created using Benzinga Pro</a>
Apple stock is currently navigating a relatively stagnant trend, but underlying buying pressure may be laying the groundwork for a bullish breakout. Apple stock, at $212.50, is trading above its eight-day and 20-day simple moving averages &#8211; $208.54 and $199.51, respectively &#8211; indicating short-term bullish momentum. This suggests that traders are stepping in to support the stock at current levels, a constructive sign for potential upside.
However, Apple stock still faces resistance on longer timeframes, as it trades below its 50-day and 200-day simple moving averages of $216.38 and $227.23. These levels suggest that the broader trend remains bearish for now. The Moving Average Convergence Divergence (MACD) reading of a negative 0.71 further supports this cautious stance, though the Relative Strength Index (RSI) at 54.2 reflects moderate bullish sentiment without being overbought. 
Overall, while Apple stock isn't yet in full bullish territory, continued buying pressure and a break above the 50-day moving average could mark a trend reversal worth watching.
<h2 class="wp-block-heading">Tariffs, AI Delays Could Mute Super Cycle Talk</h2>
Heading into earnings, expectations are being tempered by macro uncertainties. According to Hightower Advisors&#8217; Chief Investment Strategist Stephanie Link, first-quarter numbers may have seen a pull-in ahead of tariffs, but Apple may refrain from providing forward guidance. 
She points to tariffs and AI delays as reasons why she finds the scenario of a &#8220;super cycle unlikely.&#8221; Though services &#8211; expected to grow double digits &#8211; will likely be a bright spot. Still, with Apple trading at 28x earnings and showing only single-digit revenue growth, valuation could be a headwind.
<h2 class="wp-block-heading">Apple Analysts See About 4% Upside</h2>
Ratings &amp; Consensus Estimates:<a href="https://www.benzinga.com/quote/AAPL/analyst-ratings" target="_blank" rel="noreferrer noopener"> The consensus analyst rating</a> for Apple stock is currently a Buy, with a price target of $233.40. The three most recent analyst ratings for Apple stock, from Rosenblatt, Loop Capital and Barclays, imply a 3.70% upside based on their average price target of $217.
AAPL Stock Price Action: Apple stock was down 0.2% at $212.06 at the time of publication Thursday.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/25/05/45126668/apple-lied-under-oath-judge-says-tim-cook-ignored-internal-warnings-in-epic-games-case-fallout-this-is-an-injunction-not-a-negotiation">Apple Executive &#8216;Outright Lied,&#8217; Says Judge In Epic Case Fallout — Tim Cook &#8216;Chose Poorly&#8217;</a></li>
</ul>
Photo Courtesy: Tada Images on Shutterstock.com

Analyst Color

Technicals

Previews

Tech

Trading Ideas

AAPL

Apple Gears Up For Q2 Earnings With Bearish Technicals: 'Super Cycle Unlikely' Says Strategist

UBS analyst Thomas Wadewitz maintains C.H. Robinson Worldwide (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHRW#NASDAQ">CHRW</a>) with a Buy and lowers the price target from $140 to $130.

CHRW

UBS Maintains Buy on C.H. Robinson Worldwide, Lowers Price Target to $130

Piper Sandler analyst Thomas Champion maintains eBay (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EBAY#NASDAQ">EBAY</a>) with a Overweight and raises the price target from $70 to $74.

EBAY

Piper Sandler Maintains Overweight on eBay, Raises Price Target to $74

Kohl&#8217;s Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KSS#NYSE">KSS</a>) shares climbed 7.09% to $7.71 on Thursday after the company announced the termination of CEO Ashley Buchanan for cause and appointed Board Chair Michael Bender as Interim CEO.
What To Know: The board, following an investigation overseen by its Audit Committee, concluded Buchanan <a href="https://www.benzinga.com/pressreleases/25/05/b45134642/kohls-announces-ceo-transition-process">violated company policies</a> by engaging in vendor deals involving undisclosed conflicts of interest. The termination is not tied to company performance or financial reporting.
Bender, a board member since 2019 and former CEO of Eyemart Express, brings over 30 years of leadership experience at firms including Walmart, L Brands, and PepsiCo. He will remain on the board but step down from committee roles and his position as Chair. The board plans to initiate a search for a permanent CEO.
Separately, Kohl's issued <a href="https://www.benzinga.com/pressreleases/25/05/b45134642/kohls-announces-ceo-transition-process">preliminary first-quarter 2025 results</a>, expecting comparable sales to decline between 4.3% and 4.0%, operating income between $40 million and $45 million, and diluted EPS of a loss of 20 cents to a loss of 24 cents.
Full results will be released on May 29. Despite soft guidance, the leadership change and Bender's appointment were met with investor optimism.
Read Also: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/05/45137383/microsoft-rallies-after-crushing-q3-earnings-goldman-sachs-lifts-target-to-480">Microsoft Rallies After Crushing Q3 Earnings, Goldman Sachs Lifts Target To $480</a>
<h2 class="wp-block-heading">How To Buy KSS Stock</h2>
By now you're likely curious about how to participate in the market for Kohl&#8217;s &#8211; be it to purchase shares, or even attempt to bet against the company.
Buying shares is typically done through a brokerage account. You can find a list of <a href="https://www.benzinga.com/money/best-stock-trading-platforms">possible trading platforms here.</a> Many will allow you to buy &#8220;fractional shares,&#8221; which allows you to own portions of stock without buying an entire share.
In the case of Kohl&#8217;s, which is trading at $6.96 as of publishing time, $100 would buy you 14.37 shares of stock.
If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to &#8220;go short&#8221; a share of stock by lending you the shares to sell. The process of shorting a <a href="https://www.benzinga.com/money/how-to-short-a-stock">stock can be found at this resource.</a> Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading &#8211; either way it allows you to profit off of the share price decline.
According to data from&nbsp;<a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, KSS has a 52-week high of $28.25 and a 52-week low of $6.04.

Kohl's (KSS) Stock Rises On CEO Shakeup, Preliminary Q1 Outlook

Piper Sandler analyst Rob Owens maintains Confluent (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CFLT#NASDAQ">CFLT</a>) with a Overweight and lowers the price target from $40 to $32.

CFLT

Piper Sandler Maintains Overweight on Confluent, Lowers Price Target to $32

UBS analyst Radi Sultan maintains Confluent (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CFLT#NASDAQ">CFLT</a>) with a Buy and lowers the price target from $38 to $30.

UBS Maintains Buy on Confluent, Lowers Price Target to $30

Guggenheim analyst Shahriar Pourreza maintains PPL (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PPL#NYSE">PPL</a>) with a Buy and raises the price target from $38 to $40.

Guggenheim Maintains Buy on PPL, Raises Price Target to $40

Robinhood Markets, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOOD#NASDAQ">HOOD</a>) shares were trading higher Thursday but have reversed and are now trading lower. The company reported first-quarter earnings Wednesday after <a href="https://www.benzinga.com//node/45118133">the market closed</a>.
What To Know: Robinhood reported earnings per share of 37 cents, beating the consensus estimate of 32 cents. In addition, the company reported sales of $927 million, beating the consensus estimate of $922.53 million and representing a 50% year-over-year growth.
Robinhood broke down its revenue, reporting a 77% year-over-year increase in transaction-based revenue to $583 million, driven primarily by cryptocurrency, options and equities trading.
Total platform assets grew 70% year-over-year to $221 billion due to continued growth in Net Deposits and the acquisition of TradePMR.
Average revenue per user increased 39% year-over-year to $145.
&#8220;This quarter, we significantly accelerated product innovation across our key initiatives, highlighted by the announcement of Robinhood Strategies, Banking, and Cortex,&#8221;&nbsp;said Vlad Tenev, Chair and CEO of Robinhood.&nbsp;
&#8220;Customers have clearly responded — demonstrated by record-breaking net deposits, Robinhood Gold subscriptions, and options volume, as well as robust year-over-year growth in trading across all asset classes.&#8221;
Related Link: <a href="https://www.benzinga.com/news/earnings/25/05/45135625/carrier-global-reports-q1-earnings-raises-fy25-outlook-shares-move-higher">Carrier Global Reports Q1 Earnings, Raises FY25 Outlook, Shares Move Higher</a>
HOOD Price Action: At the time of writing, Robinhood stock is trading 2.63% lower at $47.92, according to data from <a href="https://www.benzinga.com/pro/">Benzinga Pro.</a>
Image: via Shutterstock

HOOD

What's Going On With Robinhood Shares Thursday?

Piper Sandler analyst Jason Bednar reiterates Pulmonx (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LUNG#NASDAQ">LUNG</a>) with a Overweight and lowers the price target from $10 to $9.

LUNG

Piper Sandler Reiterates Overweight on Pulmonx, Lowers Price Target to $9

Right Lane Industries ("Right Lane"), a privately-held industrial-holding company focused on corporate carveouts and other complex transactions, today announced that it has signed an agreement to sell TerraSource Holdings LLC ("TerraSource") to Astec Industries ("Astec") for a purchase price of $245 million. TerraSource, headquartered in Saint Louis, is a leading provider of material handling equipment and related aftermarket parts and services for crushing and separating applications globally.
Right Lane acquired a 51% interest in TerraSource from Hillenbrand, Inc. in October, 2021, and worked to enhance the scale, profitability and competitiveness of the company. Right Lane combined an aligned management team with targeted operational improvements and transformative acquisitions to create an attractive global business with significant growth prospects, ultimately delivering exceptional value for all stakeholders involved.
The transaction is expected to close by July 1, following receipt of customary regulatory approvals and other normal closing conditions. Key Banc Capital Markets advised TerraSource on the transaction, and Taft served as legal counsel.

ASTE

Right Lane Industries Agrees To Sell TerraSource Holdings To Astec Industries For $245M

Piper Sandler analyst Nathan Race maintains German American Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GABC#NASDAQ">GABC</a>) with a Neutral and lowers the price target from $44 to $42.

GABC

Piper Sandler Maintains Neutral on German American Bancorp, Lowers Price Target to $42

Piper Sandler analyst Mark Fitzgibbon maintains Columbia Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLBK#NASDAQ">CLBK</a>) with a Neutral and lowers the price target from $17 to $16.

CLBK

Piper Sandler Maintains Neutral on Columbia Financial, Lowers Price Target to $16

SUBLOCADE use during pregnancy showed no increased risk of birth defects, miscarriage, or maternal complications compared to general population rates
RICHMOND,&nbsp;Va., May 1, 2025 /PRNewswire/ -- Indivior PLC (Nasdaq/LSE: INDV) today announced the <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4418105-1&amp;h=60400520&amp;u=https%3A%2F%2Fonlinelibrary.wiley.com%2Fdoi%2Ffull%2F10.1111%2Fajad.70034&amp;a=publication">publication</a>&nbsp;of a study "Monthly Buprenorphine Depot Injection (SUBLOCADE) for Opioid Use Disorder During Pregnancy" in the American Journal on Addictions, evaluating the use of SUBLOCADE for the treatment of opioid use disorder (OUD) during pregnancy and postpartum. Three sources of data evaluated in this retrospective study illustrated that the use of monthly SUBLOCADE during pregnancy demonstrated no increased risk and is consistent with the established buprenorphine safety profile.

INDV

Indivior Announces New Study Highlighting Monthly SUBLOCADE As Potential Treatment Option For Opioid Use Disorder During and After Pregnancy

SNDL Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNDL#NASDAQ">SNDL</a>) reported first-quarter financial results before the market open on Thursday. Here&#8217;s a rundown <a href="https://www.benzinga.com/pressreleases/25/05/n45129698/sndl-reports-first-quarter-2025-financial-and-operational-results">of the report</a>. 
What Happened: SNDL reported first-quarter revenue of 204.91 million Canadian dollars ($148.47 million), missing analyst estimates of CA$243.3 million, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>. The company reported a loss of CA$0.06 per share, in line with analyst estimates.
Total revenue was up 3.6% on a year-over-year basis, primarily driven by 16.8% growth in the company&#8217;s combined cannabis business. 
&#8220;In the first quarter of 2025, we saw robust growth in our Cannabis segments and record aggregate Gross Margin. Our improvements in Free Cash Flow generation helped us nearly break even despite seasonal impacts and our unrestricted cash balances increased versus year end.&#8221; said Zach George, CEO of SNDL.
See Also: <a href="https://www.benzinga.com/government/regulations/25/04/45113866/donald-trumps-dea-nominee-reviewing-cannabis-rescheduling-will-be-one-of-my-first-priorities">Donald Trump&#8217;s DEA Nominee: Reviewing Cannabis Rescheduling Will &#8216;Be One Of My First Priorities&#8217;</a>
SNDL said it repurchased approximately 5.76 million shares of its common stock during the quarter at an average price of $1.79 per share. SNDL ended the quarter with CA$220.87 million in cash and cash equivalents. 
SNDL said its board initiated a formal strategic review to evaluate the company&#8217;s exposure to U.S. multi-state licensed cannabis enterprises and its current exchange listing status. The company noted that it has received inbound interest from multiple cannabis operators in both Canada and the U.S. in recent months, expressing interest in being acquired or pursuing asset-level or corporate transactions.
&#8220;To fully evaluate these opportunities and preserve strategic flexibility, the Board is assessing whether to maintain the Company&#8217;s current equity market listings, or transition to an alternative structure &#8211; similar to leading U.S multi-state operators who operate outside of NYSE and Nasdaq exchange frameworks,&#8221; the company said.
&#8220;Such a move would provide SNDL with the regulatory latitude to actively manage a broader North American cannabis platform, potentially consolidating licensed cannabis businesses across multiple U.S. states.&#8221;
SNDL Price Action: <a href="http://benzinga.com/quote/sndl">SNDL shares</a> were down 6.71% at $1.39 at the time of publication Thursday, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Photo: <a href="https://www.shutterstock.com/g/Plateresca">Plateresca</a>/Shutterstock.

Comments

Mapath Capital

Mapath Capital (IVFZF) オプション

No option chain data available. Please try again later

ニュース

パートナーシップ

ベンジンガ・グローバル